One Global buys 51% of Matrix Labs diagnostics arms in US$5.37M stock deal
What's the deal? One Global Service Provider LtdDealroom has a profile for this one. Try Dealroom → has approved the acquisition of a 51% controlling stake in two diagnostics firms, Matrix Labs DiagnocareDealroom has a profile for this one. Try Dealroom → and Matrix LabsDealroom has a profile for this one. Try Dealroom →. The US$5.37M deal is non-cash, settled by issuing 715,040 new equity shares to the sellers at US$7.51 each.
What's the endgame? One Global is pushing into medical diagnostics and In-Vitro Diagnostics (IVD) through inorganic growth. Folding in two established businesses gives it a foothold in both sectors and diversifies its revenue.
Why now? To fund the expansion, the board wants to double authorized share capital from US$3.4M to US$6.79M. Both moves go before shareholders at the 34th annual general meeting on September 29, 2026.
What could go wrong? The 715,040 new shares dilute existing holders. The entire transaction — plus the capital increase — still needs shareholder approval and pending regulatory clearances.
Governance note: Alongside the deal, the company reappointed S D P M & Co. as statutory auditor for a second five-year term. Valawat & Associates comes on as internal auditor for FY 2026-27, replacing Rushil Soni & Co., which resigned in August 2026.
The signal: Small listed players are using stock, not cash, to buy into India's growing diagnostics market — a route that preserves liquidity but tests shareholder appetite for dilution. The September 29 vote will decide whether One Global's bet clears.
Read more: whalesbook.com
Image credit: US Army Africa
